Summary
It is universally stated that antithyroid drugs are concentrated in human milk and are thus contraindicated during breast-feeding. We recently showed, however, that propylthiouracil (PTU) was not concentrated in milk and a study has now been made of the excretion of another widely used antithyroid drug carbimazole (CMI) in human milk. Methimazole (MMI) in blood and milk from five lactating women was measured after oral administration of CMI 40 mg, which is rapidly and completely transformed to the active antithyroid compound MMI. One hour after CMI, the mean serum-MMI reached 253 µg/l and the mean concentration of MMI in milk reached 182 µg/l. MMI was found to be unionized and not to be protein bound in serum, and it occured in milk in the same concentration as in serum; the mean milk/serum ratio was 0.98. The mean total amount of MMI excreted in milk over 8 h was 34 µg (SEM ± 5,n=5), i.e. 0.14% of the dose administered.
Similar content being viewed by others
References
Borgå O, Azarnoff DL, Forshell GP, Sjöqvist F (1969) Plasma protein binding of tricyclic antidepressant in man. Biochem Pharmacol 18:2135–2143
Crooks J, Hedley AJ, McNee C, Stevenson IH (1973) Changes in drug metabolising ability in thyroid disease. Br J Pharmacol 49:156P-157P
Gilman AG, Goodman LS, Gilman L (1980) The pharmacological basis of therapeutics, 6th ed. MacMillan, New York
Harrison's Principles of Internal Medicine (1980) 9th ed. McGraw-Hill, New York
Hervada AR, Feit E, Sagraves R (1978) Drugs in breast milk. Perinatal Care 2:19–25
Howard CP, Hayles AB (1978) Hyperthyroidism in childhood. In: Volpé R (ed) Thyreotoxicosis. Clinics in endocrinology and metabolism. Saunders London
Johansen K, Kampmann JP, Helweg J, Mølholm Hansen J (1979) Excretion of propylthiouracil in human milk. Ann Endocrinol 40:52A
Kampmann JP, Johansen K, Mølholm Hansen J, Helweg J (1980) Propylthiouracil in human milk. Revision of a dogma. Lancet 1:736–738
Low L, Lang J, Alexander WD (1979) Antithyroid drugs in human milk. Ann Endocrinol 40:52A
Melander A, Hallengren B, Rosendahl-Helgesen S, Sjöberg A-K, Wåhlin-Boll E (1980) Comparative in vitro effects and in vivo kinetics of antithyroid drugs. Eur J Clin Pharmacol 17:295–299
O'Brien TE (1974) Excretion of drugs in human milk. Am J Hosp Pharm 31:844–54
Pittman JA, Beschi RJ, Smitherman TC (1971) Methimazole: Its absorption and excretion in man and tissue distribution in rats. J Clin Endocrinol 33:182–185
Skellern GG, Knight BI, Low CKL, Alexander WD, McLarty DG, Klk WJ (1980) The pharmacokinetics of methimazole after oral administration of carbimazole and methimazole, in hyperthyroid patients. Br J Clin Pharmacol 9:137–143
Skellern GG, Knight BI, Stenlake JB (1976) Improved method for the determination of methimazole in plasma by high performance liquid chromatography. J Chromatogr 124:405–410
Skellern GG, Stenlake JB, Williams WD, McLarty DG (1974) Plasma concentrations of methimazole, a metabolite of carbimazole, in hyperthyroid patients. Br J Clin Pharmacol 1:265–269
Tegler L, Lindström B (1980) Antithyroid drugs in milk. Lancet 2:591
Update (1979) Drugs in breast milk. Med Lett Drugs Ther 21:21–24
Vesell ES, Shapiro JR, Passananti GT, Jorgensen H, Shively CA (1975) Altered plasma half-lives of antipyrine, propylthiouracil and methimazole in thyroid dysfunction. Clin Pharmacol Ther 17:48–56
Williams RH, Kay GA, Jandorf BJ (1944) Thiouracil. Its absorption, distribution and excretion. J Clin Invest 23:613–27
Wilson JT, Brown RD, Cherek DR, Dailey JW, Hilman B, Jobe PC, Manno BR, Manno JE, Redetzki & Stewart JJ (1980) Drug excretion in breast milk. Principles, pharmacokinetics and projected consequences. Clin Pharmacokinet 5:1–66
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Johansen, K., Andersen, A.N., Kampmann, J.P. et al. Excretion of methimazole in human milk. Eur J Clin Pharmacol 23, 339–341 (1982). https://doi.org/10.1007/BF00613617
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00613617